Cytomegalovirus is one of the most common causes of congenital infection. Most of infected infants will remain asymptomatic, but about 10% of infected newborns will have symptomatic disease and 10–15% will develop problems during the first 6 years of life. Symptoms of cytomegalovirus infection include growth restriction, microcephaly, seizures, hepatitis syndrome, thrombocytopenia, anemia, and pneumonitis.1
Cystic fibrosis is characterized by a progressive decline in pulmonary function secondary to chronic lung infections, exocrine pancreatic insufficiency leading to malnutrition, liver disease, and growth impairment.2 Malnutrition in cystic fibrosis results from increased energy expenditure, decreased energy intakes and malabsorption of ingested nutrients.3
Malnutrition and lung disease are inextricably woven together in cystic fibrosis. Studies have shown that lung function decline and malnutrition are related and are dependent factors. The occurrence of malnutrition is associated with reductions in lung function and survival. Chronic pulmonary infections and decreased lung function result in increased calorie needs and reduced appetite, which worsen the nutritional status of cystic fibrosis patients.4
Nutritional assessment, early identification of malnutrition, and prompt initiation of supportive treatments are essential parts of cystic fibrosis patients’ care as nutritional status can affect the patients’ response to treatment. Weight gain and normal muscle mass are linked to normal growth and good pulmonary functions.5
Here we present a case of 3-month-old infant suffering with cystic fibrosis and cytomegalovirus infection and not thriving well.
A 3-month-old male infant presented with chief complaint of cystic fibrosis and cytomegalovirus infection. He was not thriving well. At admission, his weight was 2.9 kg, height was 48 cm, head circumference was 35 cm and mid-upper arm circumference was 8.3 cm.
Infant was born through normal vaginal delivery. He was not gaining significant weight. By the end of one-month, his weight was similar to the birthweight (2.9 kg).
Infant was on breastfeeding. Since, he was unable to gain weight therefore started on formula feeding in addition to breast milk.
Sweat chloride test, polymerase chain reaction (PCR) and complete blood count (CBC) were ordered.
Both sweat chloride test and PCR came out positive. Infant was diagnosed to be suffering with cystic fibrosis and cytomegalovirus infection. CBC report revealed severe anemia and thrombocytopenia.
Since patient’s weight was less than 3rd percentile on WHO growth chart, he was found to be suffering from severe faltering growth.
Cytomegalovirus infection was managed using Valganciclovir and cystic fibrosis was managed using nutritional management. Aim of the nutritional management was to achieve satisfactory weight gain. In addition to that normal growth and development of infant was desired.
Infant was hospitalized for period of 10 days. He was started on breastfeeding and energy and nutrient dense formula (ENDF) top ups. Around 50ml/kg/day of ENDF were given every 3 hourly. Total 7-8 feeds were given per day. Infant tolerated the formula well and started gaining weight by day 6 of hospital stay. Infant gained 500 g of weight over a 10 days period making his weight 3.4 kg at the time of discharge.
ENDF was continued post discharge along with breastfeeding. Infant was started on weaning food from 5th month of age. Especial diet was advised for managing cystic fibrosis.
Infant gained 2.2 kg of weight making his weight 5.6 kg at 6 months. His growth and development improved significantly. Infant’s height was 55 cm, head circumference was 40 cm, and mid upper arm circumference was 10 cm. He was able to hold neck and turn over.


Cytomegalovirus, a member of the human herpesvirus family, is the most common viral cause of congenital infection, affecting 0.2–2.2% of all live births. It is responsible for significant morbidity, especially in infants who are symptomatic in the neonatal period.6 Early cytomegalovirus infection, namely in utero or during early infancy, may contribute to reduced growth, altered or impaired immune functions, and sensory and cognitive deficits.7
Cystic fibrosis causes thickening of mucous that primarily affects the pulmonary and gastrointestinal systems. Thickening of the airway mucous blocks gas exchange and provides a growth medium for bacteria, which then leads to airway inflammation and infection, causing permanent lung damage, chronic sinus problems, or both. In the gastrointestinal system, the thickened mucous decreases pancreatic enzyme secretion into the intestine and absorption of nutrients, causing problems with malabsorption that can lead to malnutrition.8
Cystic fibrosis is strongly associated with poor nutritional status linked directly by factors related to the underlying genetic mutation, as well as indirectly by factors such as higher energy needs, energy losses, greater essential fatty acid turnover, and decreased nutrient intake and absorption.9
In infants with cystic fibrosis, poor nutritional status results in stunted growth, as detected by low weight- and height for- age percentiles. If untreated, such cystic fibrosis-related undernutrition in infancy can lead to the serious consequence of impaired cognitive function. In cases of severe undernutrition in infants, lung function worsens markedly, and survival is poor.9
Initiation of nutritional management should begin as early as possible after diagnosis. Energy intake should be increased for breastfed infants who have poor weight gain despite efforts to optimize pancreatic enzyme replacement therapy by providing more frequent feedings and fortifying expressed breast milk. For formula fed infants, energy and protein intake can be increased by using high-energy/protein infant formula.9 Energy and nutrient dense formula (ENDF) may help in weight gain in infants with faltering growth. In a study by Clarke SE et al., all 49 infants [median age of 5 weeks (range 2-31 weeks)] with faltering growth gained weight with ENDF. Intake of ENDF also resulted in significantly greater intakes of all nutrients, protein, sodium, potassium, calcium, zinc, iron, vitamin D, vitamin C and vitamin A.10
In the case presented here, infant was showing faltering growth due to cystic fibrosis and cytomegalovirus infection. He was unable to gain weight with breast feeding and regular formula feeding. Infant therefore started on ENDF along with breastfeeding. ENDF led to satisfactory weight gain. Use of ENDF can be considered as one of the important measures in infants who are not thriving well.
We can conclude that ENDF can help in managing infant with faltering growth. Nutritional management is of utmost importance in any failure to thrive case. In infants less than 6 months, where solids are not an option, giving ENDF would be of great benefit.
References:-
Walter-Nicolet E, Leblanc M, et al. Congenital cytomegalovirus infection manifesting as neonatal persistent pulmonary hypertension: report of two cases. Pulm Med. 2011;2011:293285
Kulkarni H, Kansra S, et al. Cystic fibrosis revisited. J Postgrad Med. 2019 Oct-Dec;65(4):193-196
Hankard R, Munck A, Navarro J. Nutrition and growth in cystic fibrosis. Horm Res. 2002;58 Suppl 1:16-20.
Barni GC, Forte GC, et al. Factors associated with malnutrition in adolescent and adult patients with cystic fibrosis. J Bras Pneumol. 2017 Sep-Oct;43(5):337-343
Isa HM, Al-Ali LF, Mohamed AM. Growth assessment and risk factors of malnutrition in children with cystic fibrosis. Saudi Med J. 2016 Mar;37(3):293-8.
Khalil A, Heath P, Jones C, Soe A, Ville YG on behalf of the Royal College of Obstetricians and Gynecologists. Congenital Cytomegalovirus Infection: Update on Treatment. BJOG. 2018 Jan;125(1):e1-e11.
Filteau S, Rowland-Jones S. Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children. Front Immunol. 2016 Jun 30;7:257
Pitts J, Flack J, Goodfellow J. Improving nutrition in the cystic fibrosis patient. J Pediatr Health Care. 2008 Mar-Apr;22(2):137-40
Turck D, Braegger CP, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016 Jun;35(3):557-77.
Clarke SE, Evans S, et al. Randomized comparison of a nutrient-dense formula with an energy-supplemented formula for infants with faltering growth. J Hum Nutr Diet. 2007 Aug;20(4):329-39.
Important Notice:
The World Health Organization (WHO)* has recommended that pregnant women and new mothers be informed of the benefits and superiority of breast-feeding, in particular, the fact that it provides the best nutrition and protection from illness for babies. Mothers should be given guidance on the preparation for and maintenance of lactation, with special emphasis on the importance of the well-balanced diet both during pregnancy and after delivery. Unnecessary introduction of partial bottle feeding or other foods and drinks should be discouraged since it will have a negative effect on breast-feeding. Similarly mothers should be warned of the difficulty of reversing a decision not to breastfeed. Before advising a mother to use an infant formula, she should be advised of the social and financial implications of her decision. For example, if a baby is exclusively bottle-fed, more than one can (500g) per week will be needed, so the family circumstances and cost should be kept in mind. Mother should be reminded that breast milk is not only the best but also the most economical food for babies. If a decision to use infant formula is taken, it is important to give instruction on correct preparation methods, emphasizing that unboiled water, unsterilized bottles or incorrect dilution can lead to illness.
*See: International Code of Marketing of Breast Milk Substitutes, adopted by the World Health Assembly in Resolution WHA 34.22, May 1981.
Mothers should be explained the following advantages & nutritional superiority of breastfeeding:
Details of management of breast feeding, as under: